$27.06
0[0.00%]
Last update: 4:20PM Get Real Time Here
Arcturus Therapeutics
(NASDAQ:ARCT)Arcturus Therapeutics Stock (NASDAQ:ARCT), Earnings Estimates, EPS, and Revenue
Arcturus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-1.190
Quarterly Revenue Estimate
$20.7M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$157.7M
Analyze the earnings history of Arcturus Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/07/2024 | PM | ARCT | Q1 | $1.87 | -$1.19 | — | — | $80.28M | $20.66M | — | — | Get Alert |
| 03/07/2024 | PM | ARCT | Q4 | $4.33 | -$0.99 | -$0.32 | 67.68% | $160.29M | $37.86M | $33.99M | -10.22% | Get Alert |
| 11/14/2023 | PM | ARCT | Q3 | -$1.33 | -$1.69 | -$0.61 | 63.91% | $13.37M | $15.86M | $45.14M | 184.62% | Get Alert |
| 08/07/2023 | PM | ARCT | Q2 | -$0.82 | -$0.21 | -$1.98 | -842.86% | $27.09M | $48.50M | $10.52M | -78.31% | Get Alert |
| 05/09/2023 | PM | ARCT | Q1 | -$1.94 | $0.06 | $0.62 | 933.33% | $5.24M | $37.94M | $80.28M | 111.61% | Get Alert |
| 03/28/2023 | PM | ARCT | Q4 | -$1.47 | $0.98 | $4.33 | 341.84% | $5.79M | $72.68M | $160.29M | 120.55% | Get Alert |
| 11/09/2022 | PM | ARCT | Q3 | -$2.05 | -$1.81 | -$1.33 | 26.52% | $2.44M | $3.42M | $13.37M | 290.91% | Get Alert |
| 08/09/2022 | PM | ARCT | Q2 | -$2.07 | -$1.90 | -$0.82 | 56.84% | $2.00M | $2.09M | $27.09M | 1196.32% | Get Alert |
| 05/09/2022 | PM | ARCT | Q1 | -$2.15 | -$1.44 | -$1.94 | -34.72% | $2.13M | $6.30M | $5.24M | -16.76% | Get Alert |
| 02/28/2022 | PM | ARCT | Q4 | -$1.25 | -$1.72 | -$1.47 | 14.53% | $2.24M | — | $5.79M | — | Get Alert |
| 11/08/2021 | PM | ARCT | Q3 | -$0.92 | -$1.59 | -$2.05 | -28.93% | $2.33M | — | $2.44M | — | Get Alert |
| 08/09/2021 | PM | ARCT | Q2 | -$0.55 | -$2.14 | -$2.07 | 3.27% | $2.32M | $2.32M | $2.00M | -13.75% | Get Alert |
| 05/10/2021 | PM | ARCT | Q1 | -$0.67 | -$1.25 | -$2.15 | -72.00% | $2.65M | $2.54M | $2.13M | -16.26% | Get Alert |
| 03/01/2021 | PM | ARCT | Q4 | -$0.76 | -$0.88 | -$1.25 | -42.05% | $2.97M | $2.36M | $2.24M | -5.17% | Get Alert |
| 11/09/2020 | PM | ARCT | Q3 | -$0.56 | -$0.49 | -$0.92 | -87.76% | $3.32M | $3.00M | $2.33M | -22.23% | Get Alert |
| 08/10/2020 | PM | ARCT | Q2 | -$0.07 | -$0.55 | -$0.55 | 0.00% | $10.15M | $3.54M | $2.32M | -34.41% | Get Alert |
| 05/07/2020 | PM | ARCT | Q1 | — | -$0.61 | -$0.67 | -9.84% | — | $4.97M | $2.65M | -46.76% | Get Alert |
| 03/11/2020 | PM | ARCT | Q4 | -$0.10 | — | -$0.76 | — | — | $3.37M | $2.97M | -11.93% | Get Alert |
| 11/08/2019 | AM | ARCT | Q3 | — | — | -$0.56 | — | — | — | $3.32M | — | Get Alert |
FAQ
When is Arcturus Therapeutics (NASDAQ:ARCT) reporting earnings?
Arcturus Therapeutics (ARCT) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on March 7, 2024 for Q4.
What were the latest earnings per share (EPS) for Arcturus Therapeutics (NASDAQ:ARCT)?
The Actual EPS was $-0.32, which beat the estimate of $-0.99.
What were Arcturus Therapeutics’s (NASDAQ:ARCT) revenues?
The Actual Revenue was $34M, which missed the estimate of $37.9M.
Browse earnings estimates, EPS, and revenue on all stocks.